ReviewDiabetes technology & therapeutics2015
An Overview of Current Regulatory Requirements for Approval of Biosimilar Insulins.
Lutz Heinemann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this paperpooled ittrialcites it